Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000595106 | SCV000704651 | uncertain significance | not provided | 2016-12-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000803680 | SCV000943562 | uncertain significance | Autosomal recessive polycystic kidney disease | 2021-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with tryptophan at codon 73 of the PKHD1 protein (p.Arg73Trp). The arginine residue is weakly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs567357782, ExAC 0.02%). This variant has not been reported in the literature in individuals affected with PKHD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 499252). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002483603 | SCV002792352 | uncertain significance | Polycystic kidney disease 4 | 2022-01-25 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000803680 | SCV001453464 | uncertain significance | Autosomal recessive polycystic kidney disease | 2018-07-24 | no assertion criteria provided | clinical testing | |
Laboratory of Gastroenterology and Hepatology, |
RCV001844838 | SCV001876977 | uncertain significance | Autosomal dominant polycystic liver disease | 2021-09-01 | no assertion criteria provided | research |